
|Videos|September 29, 2021
Dr. Chancellor discusses novel regenerative therapy for recurrent SUI
Author(s)Urology Times staff
Advertisement
In this video, Michael B. Chancellor, MD, discusses the background, findings and takeaways of the study, “An evaluation of women with persistent or recurrent stress urinary incontinence (SUI) following surgery in a double-bling, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO),” presented at the 2021 American Urological Association Annual Meeting. Chancellor is a professor and director of neurourology at Oakland University, Royal Oak, Michigan.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Team-based AE protocols improve consistency with the gemcitabine intravesical therapy system
2
Practical tips for AE management with the gemcitabine intravesical system
3
Study to assess adaptive-dosed 177Lu-DOTA-HYNIC-panPSMA in mHSPC
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5












